DataMEDS AI Inc (MEDS)

NASD · Healthcare · Medical Distribution · USA

DataMEDS AI Inc is a micro cap company (market value under $300 million) in the Medical Distribution industry.

DataMEDS AI Inc is a holding company operating through subsidiaries in pharmaceuticals and healthcare services. The company owns a specialty pharmacy, wholesale distribution operations, and a technology platform providing hub and clinical services to independent pharmacies. It serves patients, healthcare providers, pharmaceutical manufacturers, and payors by offering specialty and general pharmaceutical products, care coordination, and digital health tools.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the DataMEDS AI Inc stock.

Our verdict on MEDS

Not valued: We cannot value this company yet.

We do not publish a value for this company: its filings cover two fiscal years and projecting growth needs four in a row.

ETFs with the most weight in MEDS

Browse

Peers in Medical Distribution

All 11 Medical Distribution stocks

Cheaper than MEDS in Medical Distribution

Is MEDS undervalued or overvalued?

We do not publish a verdict on MEDS yet. A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover two fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.

What is the intrinsic value of MEDS?

We do not publish one (as of the 2026-11-17 close). A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover two fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.